BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34212389)

  • 21. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity.
    Dai X; Chang P; Zhu Q; Liu W; Sun Y; Zhu S; Jiang Z
    Neurosci Lett; 2013 Oct; 554():64-9. PubMed ID: 23999027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles and Interaction of the MAPK Signaling Cascade in Aβ25-35-Induced Neurotoxicity Using an Isolated Primary Hippocampal Cell Culture System.
    Iloun P; Hooshmandi E; Gheibi S; Kashfi K; Ghasemi R; Ahmadiani A
    Cell Mol Neurobiol; 2021 Oct; 41(7):1497-1507. PubMed ID: 32601776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN.
    Gwon Y; Kim SH; Kim HT; Kam TI; Park J; Lim B; Cha H; Chang HJ; Hong YR; Jung YK
    FASEB J; 2019 Mar; 33(3):4300-4313. PubMed ID: 30540497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In vitro Model of Alzheimer's Disease.
    Burgaletto C; Di Benedetto G; Munafò A; Bernardini R; Cantarella G
    Curr Alzheimer Res; 2021; 18(4):298-309. PubMed ID: 34102970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.
    Miller EC; Teravskis PJ; Dummer BW; Zhao X; Huganir RL; Liao D
    Eur J Neurosci; 2014 Apr; 39(7):1214-24. PubMed ID: 24713000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
    Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
    J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
    He B; Chen W; Zeng J; Tong W; Zheng P
    J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer's Disease Cell Model via the p38 MAPK/JNK Pathway.
    Wang Q; Jiang H; Wang L; Yi H; Li Z; Liu R
    J Alzheimers Dis; 2019; 72(1):199-214. PubMed ID: 31561371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.
    Stein TD; Anders NJ; DeCarli C; Chan SL; Mattson MP; Johnson JA
    J Neurosci; 2004 Sep; 24(35):7707-17. PubMed ID: 15342738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotinic Acetylcholine Receptors Sensitize a MAPK-linked Toxicity Pathway on Prolonged Exposure to β-Amyloid.
    Arora K; Cheng J; Nichols RA
    J Biol Chem; 2015 Aug; 290(35):21409-20. PubMed ID: 26139609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
    Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
    Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
    Wan J; Fu AK; Ip FC; Ng HK; Hugon J; Page G; Wang JH; Lai KO; Wu Z; Ip NY
    J Neurosci; 2010 May; 30(20):6873-81. PubMed ID: 20484629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.